Hamburg said the FDA is planning to expand its staff in India to 19 from 12 as it tries to assure the safety of medications from India.
Describing India as a nation which is of “particularly important” to US food and drug trade, she said the fact that the US has increased its presence in India reflects that India is a very significant and growing player in the US marketplace with respect to both pharmaceutical products and food. During her over a week-long travel to India from February 10 to 18, the two countries signed their first statement of intent to cooperate in the field of medical products. Hamburg said the US wants to ensure the quality and availability of the products. “That is our greatest goal and we do think that, the work in India is important to that overall effort because they are such a significant supplier of drugs to this country.” The FDA chief said she has already visited China twice and other countries as well and plans to continue to engage with other nations. “India, such an important player, needs to be a full participant at the table,” she said in response to a question. Hamburg said there needs to be a global coalition of regulators as they together try to address the challenges of an increasingly complex globalized world. (PTI)